94-23506. Riker Laboratories, Inc., et al.; Withdrawal of Approval of 91 New Drug Applications; Correction

[Federal Register Volume 59, Number 183 (Thursday, September 22, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-23506]


[[Page Unknown]]

[Federal Register: September 22, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. 94N-0044]

 

Riker Laboratories, Inc., et al.; Withdrawal of Approval of 91 
New Drug Applications; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a 
document that withdrew approval of 91 new drug applications (NDA's). 
The document was published in the Federal Register of March 2, 1994 (59 
FR 9989). This document corrects the name of one of the drugs.

FOR FURTHER INFORMATION CONTACT: Nancy G. Maizel, Center for Drug 
Evaluation and Research (HFD-53), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-443-4320.

SUPPLEMENTARY INFORMATION:  In FR Doc. 94-4660, appearing on page 9989, 
in the Federal Register of Wednesday, March 2, 1994, the following 
correction is made:
    In the table on page 9991 in the entry for NDA 17-485, the drug 
name ``Vosol Otic Solution'' is corrected to read ``Vosol Wick Otic 
Solution.''

    Dated: September 2, 1994.
Janet Woodcock,
Director, Center for Drug Evaluation and Research.
[FR Doc. 94-23506 Filed 9-21-94; 8:45 am]
BILLING CODE 4160-01-F